Market: NMS |
Currency:
Address:
📈 BULL Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$11.00
-
Upside/Downside from Analyst Target:
40.31%
-
Broker Call:
8
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
>500%
-
Revenue Growth Range (1Y):
100-200%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for BULL
No earnings history available for this symbol.
📰 Related News & Research
-
Seatrium Ltd Technical Analysis: Bullish Outlook & Key Price Levels for 2026 1
March 27, 2026
Broker Name: Lim & Tan Securities Date of Report: 27 March...
-
Seatrium Ltd Technical Analysis March 2026: Bullish Outlook, Key Support & Resistance Levels Revealed
March 27, 2026
Broker Name: Lim & Tan Securities Date of Report: 27 March...
-
BullFrog AI Holdings: Advanced AI/ML Platforms for Drug Discovery, Clinical Data Analysis, and Pharmaceutical Innovation
March 20, 2026
BullFrog AI Holdings, Inc. (BFRG) - 2025 Annual Report: Key ...
-
Monthly Technical Outlook: Bullish Trends & Strategies for FBMKLCI, JCI, SET & STI Indices (March 2026) 1
March 17, 2026
Broker Name: UOB Kay Hian Date of Report: Friday, 13 March...
-
Silver Bull Resources, Inc. 2026 Q1 Financials: Exploration Update, Legal Proceedings, and Financial Statements Overview
March 14, 2026
Silver Bull Resources, Inc. Releases Q1 2026 Financial Resul...
-
Sembcorp Industries Technical Analysis: Bullish Short-Term Outlook & Key Price Levels (March 2026)
March 13, 2026
Broker: Lim & Tan Securities Date of Report: 13 March 2026...
-
Monthly Regional Indices Technical Outlook March 2026: Bullish FBMKLCI, Bearish JCI, SET Sideways, Strong STI Trends 1
March 13, 2026
Broker Name: UOB Kay Hian Date of Report: Friday, 13 March 2...
-
Sembcorp Industries Technical Analysis 2026: Bullish Short-Term Outlook, Key Resistance & Support Levels
March 13, 2026
Broker Name: Lim & Tan Securities Date of Report: 13 March 2...
-
Keppel Ltd Technical Analysis: Bullish Short-Term Outlook with Key Support & Resistance Levels (March 2026) 1
March 11, 2026
Broker Name: Lim & Tan Securities Date of Report: 10 March 2...
-
Abeona Therapeutics Announces Momentum in ZEVASKYN® Gene Therapy Launch for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
March 9, 2026
Abeona Therapeutics Provides Detailed Business Update on ZEV...
🔍 View more Reports